相关实验视频

Updated: Jun 11, 2025

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Published on: April 13, 2015

液-液相分离在瘤免疫中的新兴作用

Yuan-Tong Liu¹, Lin-Yu Cao², Zhi-Jun Sun²

¹State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Frontier Science Center for Immunology and Metabolism, Taikang Center for Life and Medical Sciences, Wuhan University, Wuhan, China; Department of Stomatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

International immunopharmacology

|October 1, 2024

概括

液-液相分离 (LLPS) 组织免疫信号分子,提供克服瘤免疫逃避和抗癌免疫疗法的新方法. 这种生物物理过程为增强癌症治疗提供了新的治疗策略.

科学领域:

生物物理学的生物物理.
免疫学免疫学免疫学
癌症生物学癌症生物学

背景情况:

瘤免疫疗法,特别是PD-1向治疗,显示出希望,但面临诸如治疗耐药性和瘤免疫逃避等挑战.
了解复杂的免疫信号通路对于推进癌症治疗至关重要.

研究的目的:

批判性地分析液-液相分离 (LLPS) 在瘤免疫中的作用.
探索LLPS对免疫信号通路的影响及其对新型癌症治疗的潜力.

主要方法:

关于LLPS机制在免疫信号传递中的最新文献的综述.
对LLPS在T细胞受体 (TCR),B细胞受体 (BCR),免疫检查点和先天免疫通路 (例如cGAS-STING,压力颗粒,ADP-肝素-ALPK1) 中的作用的分析.

主要成果:

LLPS是一种生物物理过程,它将生物宏分子组织成类似液体的凝聚物,影响信号集群和免疫分子功能.
LLPS影响关键的免疫信号通路与瘤免疫相关,包括TCR,BCR和先天免疫反应.

结论:

在LLPS提供了对免疫信号的新视角,并为开发创新的癌症疗法提供了机会.
利用LLPS可以克服癌症治疗当前的障碍,并改善免疫治疗结果.

关键词:

免疫信号传递免疫信号传递免疫治疗是一种免疫疗法.液态液态相隔离器液态液态相隔离器瘤免疫系统的免疫力瘤微环境是一个微环境.

更多相关视频

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Published on: June 7, 2018

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...